Aprea Therapeutics, Inc. (NASDAQ:APRE) IPO
IPO
Priced at US$15.00 a share on Oct 2, 2019.
- Price
- US$15.00 a share
- Shares offered
- 5,666,667 shares of common stock
- Offering size
- US$85 million
- Underwriters' option
- Up to 850,000 more shares
- Listing
- APRE on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Morgan Stanley, RBC Capital Markets · In the order on the cover
- Shares delivered
- On or about Oct 7, 2019
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 12, 2019 |
| Filed publicly | Sep 6, 2019 |
| Amended 4 times | Newest Oct 2, 2019 |
| Shares registered with an exchange | Sep 30, 2019 |
| Declared effective by the SEC | Oct 2, 2019 |
| Final prospectus, with the price | Oct 4, 2019 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 4, 2019 |
| FWP · Free writing prospectus | Oct 3, 2019 |
| EFFECT · Notice that a registration is effective | Oct 2, 2019 |
| S-1MEF · Registration of more shares for the same offering | Oct 2, 2019 |
| CERT · Exchange's certificate of listing | Oct 2, 2019 |
| S-1/A · Registration statement, amended | Oct 2, 2019 |
| CORRESP · Letter to the SEC | Sep 30, 2019 |
| CORRESP · Letter to the SEC | Sep 30, 2019 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 30, 2019 |
| S-1/A · Registration statement, amended | Sep 27, 2019 |
| CORRESP · Letter to the SEC | Sep 25, 2019 |
| S-1/A · Registration statement, amended | Sep 25, 2019 |
| UPLOAD · Letter from the SEC | Sep 24, 2019 |
| S-1/A · Registration statement, amended | Sep 23, 2019 |
| CORRESP · Letter to the SEC | Sep 16, 2019 |
| S-1 · Registration statement | Sep 6, 2019 |
| DRS/A · Draft registration statement, amended | Aug 20, 2019 |
| DRSLTR · Letter to the SEC with a draft | Aug 20, 2019 |
| UPLOAD · Letter from the SEC | Aug 8, 2019 |
| DRS · Draft registration statement | Jul 12, 2019 |
From the cover of the final prospectus (424B4) filed Oct 4, 2019